Homepage | The Journal for ImmunoTherapy of Cancer
2 天之前 · The Journal for ImmunoTherapy of Cancer is an open access journal that publishes high quality research, literature reviews, position papers and practice guidelines, and case studies on all components of cancer immunology and immunotherapy.
Authors - The Journal for ImmunoTherapy of Cancer
The Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. It publishes original research articles under several sections: Basic and ...
About - The Journal for ImmunoTherapy of Cancer
The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many ...
Current Issue | Journal for ImmunoTherapy of Cancer
2024年11月4日 · Original research: Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures (4 November, 2024)
Editorial Board - The Journal for ImmunoTherapy of Cancer
Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.
Table of contents | Journal for ImmunoTherapy of Cancer
2024年9月4日 · Original research: Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study (3 September, 2024)
Case Reports Archives - The Journal for ImmunoTherapy of Cancer
Complete response to immunotherapy in a patient with high-risk stage III colorectal cancer after ctDNA-guided detection of early adjuvant treatment failure
Table of contents | Journal for ImmunoTherapy of Cancer
Original research: Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (9 May, 2024)
Table of contents | Journal for ImmunoTherapy of Cancer
2023年1月2日 · Original research: Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model (12 January, 2023)
Commentary/Editorials Archives - The Journal for ImmunoTherapy …
2024年10月26日 · Minority report on cancer immunotherapy: focus on elderly and other understudied populations